$VRTX
Vertex Pharmaceuticals Inc

2013 Q1 Form 10-Q Financial Statement

#000087532013000024 Filed on May 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $328.4M $438.7M
YoY Change -25.16% 495.61%
Cost Of Revenue $30.96M $25.92M
YoY Change 19.43%
Gross Profit $297.4M $412.8M
YoY Change -27.96% 460.42%
Gross Profit Margin 90.57% 94.09%
Selling, General & Admin $91.63M $111.1M
YoY Change -17.56% 55.4%
% of Gross Profit 30.81% 26.92%
Research & Development $210.2M $196.4M
YoY Change 7.04% 23.81%
% of Gross Profit 70.68% 47.57%
Depreciation & Amortization $10.69M $8.560M
YoY Change 24.89% -3.82%
% of Gross Profit 3.59% 2.07%
Operating Expenses $301.8M $307.5M
YoY Change -1.85% 33.62%
Operating Profit -$429.1M $91.65M
YoY Change -568.24% -157.32%
Interest Expense -$3.469M -$150.0K
YoY Change 2212.67% -101.25%
% of Operating Profit -0.16%
Other Income/Expense, Net -$1.175M -$3.741M
YoY Change -68.59%
Pretax Income -$433.8M $87.91M
YoY Change -593.45% -149.92%
Income Tax -$126.9M $32.00K
% Of Pretax Income 0.04%
Net Earnings -$308.0M $91.59M
YoY Change -436.3% -152.01%
Net Earnings / Revenue -93.8% 20.88%
Basic Earnings Per Share -$1.43 $0.44
Diluted Earnings Per Share -$1.43 $0.43
COMMON SHARES
Basic Shares Outstanding 215.4M shares 208.0M shares
Diluted Shares Outstanding 215.4M shares 219.3M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.239B $981.0M
YoY Change 26.3% 19.2%
Cash & Equivalents $379.1M $454.1M
Short-Term Investments $860.0M $713.0M
Other Short-Term Assets $111.0M $93.00M
YoY Change 19.35% 257.69%
Inventory $21.53M $130.0M
Prepaid Expenses
Receivables $194.1M $232.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.566B $1.436B
YoY Change 9.04% 64.49%
LONG-TERM ASSETS
Property, Plant & Equipment $504.2M $170.3M
YoY Change 196.03% 139.9%
Goodwill $30.99M $30.99M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.693M $10.82M
YoY Change -19.63% -78.37%
Total Long-Term Assets $826.5M $910.0M
YoY Change -9.18% 36.84%
TOTAL ASSETS
Total Short-Term Assets $1.566B $1.436B
Total Long-Term Assets $826.5M $910.0M
Total Assets $2.392B $2.346B
YoY Change 1.97% 52.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.63M $73.23M
YoY Change -18.57% 109.22%
Accrued Expenses $274.1M $241.5M
YoY Change 13.49% 88.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.000M
YoY Change
Total Short-Term Liabilities $407.6M $357.0M
YoY Change 14.18% -14.18%
LONG-TERM LIABILITIES
Long-Term Debt $732.0M $400.0M
YoY Change 83.0% 0.0%
Other Long-Term Liabilities $16.68M $10.89M
YoY Change 53.22% -93.6%
Total Long-Term Liabilities $16.68M $10.89M
YoY Change 53.22% -98.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $407.6M $357.0M
Total Long-Term Liabilities $16.68M $10.89M
Total Liabilities $1.415B $1.415B
YoY Change 0.03% 23.37%
SHAREHOLDERS EQUITY
Retained Earnings -$3.830B
YoY Change
Common Stock $4.577B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $746.1M $930.0M
YoY Change
Total Liabilities & Shareholders Equity $2.392B $2.346B
YoY Change 1.97% 52.54%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$308.0M $91.59M
YoY Change -436.3% -152.01%
Depreciation, Depletion And Amortization $10.69M $8.560M
YoY Change 24.89% -3.82%
Cash From Operating Activities -$65.78M $2.916M
YoY Change -2355.76% -101.56%
INVESTING ACTIVITIES
Capital Expenditures $16.61M $6.155M
YoY Change 169.81% -225.61%
Acquisitions
YoY Change
Other Investing Activities -$472.0K $216.0K
YoY Change -318.52% -99.95%
Cash From Investing Activities -$37.60M -$231.7M
YoY Change -83.77% -157.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.100M 21.50M
YoY Change -128.37% -231.1%
NET CHANGE
Cash From Operating Activities -$65.78M $2.916M
Cash From Investing Activities -37.60M -231.7M
Cash From Financing Activities -6.100M 21.50M
Net Change In Cash -$65.78M $2.916M
YoY Change -2355.76% -98.56%
FREE CASH FLOW
Cash From Operating Activities -$65.78M $2.916M
Capital Expenditures $16.61M $6.155M
Free Cash Flow -$82.39M -$3.239M
YoY Change 2443.53% -98.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
101292000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
59627000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
194054000 USD
CY2012Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
227000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143250000 USD
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
274061000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264884000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1149000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-550000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4519448000 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4574987000 USD
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27938000 USD
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31574000 USD
CY2013Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
285300000 USD
CY2013Q1 us-gaap Assets
Assets
2392234000 USD
CY2012Q4 us-gaap Assets
Assets
2759288000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1589585000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
1565783000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
831808000 USD
CY2013Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
860255000 USD
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
13707000 USD
CY2013Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
8302000 USD
CY2013Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14755000 USD
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15170000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
379099000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489407000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475320000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267923000 USD
CY2013Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
60100000 USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
217286868 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
218651704 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
218651704 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
217286868 shares
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
2160000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2149000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
92015000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-308615000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4611000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3714000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-313226000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
88301000 USD
CY2013Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
356900000 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
290700000 USD
CY2013Q1 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
400000000 USD
CY2012Q4 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
400000000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
30955000 USD
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
25918000 USD
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
766656000 USD
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
347088000 USD
CY2013Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
127600000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
27566000 USD
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
35533000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
96242000 USD
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
90297000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2600000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1500000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
280367000 USD
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
151664000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8560000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10691000 USD
CY2013Q1 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
11788000 USD
CY2012Q1 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
13293000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-136000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-799000 USD
CY2012Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
250000 USD
CY2013Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
299000 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
227000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
227000 USD
CY2013Q1 us-gaap Extraordinary Item Earnings Per Share Impact Net
ExtraordinaryItemEarningsPerShareImpactNet
1.32
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000 USD
CY2012Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2012Q4 us-gaap Goodwill
Goodwill
30992000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
30992000 USD
CY2013Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2012Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2013Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
412900000 USD
CY2012Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-442940000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
87908000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-130313000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000 USD
CY2013Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1541000 USD
CY2012Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1400000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-40571000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
49093000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48834000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
23236000 USD
CY2012Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-15769000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-16452000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2022000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16915000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9231000 USD
CY2012Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-2281000 USD
CY2013Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-128703000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
20541000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24986000 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-6975000 USD
CY2012Q1 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
6139000 USD
CY2013Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2012Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
8891000 shares
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15393000 USD
CY2013Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13806000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
21532000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
30464000 USD
CY2013Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4796000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3754000 USD
CY2013Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2930000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11317000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
1415402000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1524906000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2392234000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2759288000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
432624000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
407639000 USD
CY2013Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2012Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
196672000 USD
CY2013Q1 us-gaap Minority Interest
MinorityInterest
191845000 USD
CY2012Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
460000 USD
CY2013Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
342000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-207397000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-110308000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6135000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
21525000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-37596000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-231702000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65778000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2916000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-308016000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
91590000 USD
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4611000 USD
CY2012Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3714000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-308016000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
90684000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-308016000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
94479000 USD
CY2012Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
38229000 USD
CY2013Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
66052000 USD
CY2013Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
91649000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-438288000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9668000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8693000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
275000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-610000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
425000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-599000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
150000 USD
CY2012Q4 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
663500000 USD
CY2013Q1 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
250600000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20417000 USD
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25205000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16678000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13902000 USD
CY2013Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
2432000 USD
CY2012Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
2292000 USD
CY2013Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
998000 USD
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-18000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4652000 USD
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3741000 USD
CY2012Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
216000 USD
CY2013Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-472000 USD
CY2012Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
403179000 USD
CY2013Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
458971000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16607000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6155000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24673000 USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47835000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21670000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21298000 USD
CY2013Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17709000 USD
CY2012Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2012Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
183987000 USD
CY2013Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
430535000 USD
CY2012Q1 us-gaap Profit Loss
ProfitLoss
87876000 USD
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-312627000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
504232000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
433609000 USD
CY2012Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
38530000 USD
CY2013Q1 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
38872000 USD
CY2012Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
10096000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
218095000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
196371000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
69983000 USD
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
63008000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
31934000 USD
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
31934000 USD
CY2013Q1 us-gaap Restructuring Charges
RestructuringCharges
39000 USD
CY2012Q1 us-gaap Restructuring Charges
RestructuringCharges
360000 USD
CY2012Q1 us-gaap Restructuring Reserve
RestructuringReserve
25473000 USD
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
26313000 USD
CY2013Q1 us-gaap Restructuring Reserve
RestructuringReserve
22459000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
23328000 USD
CY2013Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4911000 USD
CY2012Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4758000 USD
CY2012Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
18570000 USD
CY2013Q1 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
17548000 USD
CY2012Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-840000 USD
CY2013Q1 us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-869000 USD
CY2012Q1 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
3686000 USD
CY2013Q1 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
3573000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3829883000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3521867000 USD
CY2012Q1 us-gaap Revenues
Revenues
438737000 USD
CY2013Q1 us-gaap Revenues
Revenues
328368000 USD
CY2013Q1 us-gaap Royalty Revenue
RoyaltyRevenue
43573000 USD
CY2012Q1 us-gaap Royalty Revenue
RoyaltyRevenue
38981000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
267381000 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
375375000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
92879000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
111146000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
27688000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
31275000 USD
CY2013Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
24102000 USD
CY2012Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
23599000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
999180000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
746115000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1195852000 USD
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
937960000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
928476000 USD
CY2012Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1068081000 USD
CY2012Q1 us-gaap Undistributed Earnings
UndistributedEarnings
-906000 USD
CY2013Q1 us-gaap Undistributed Earnings
UndistributedEarnings
0 USD
CY2013Q1 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
0 USD
CY2012Q1 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
-860000 USD
CY2012Q4 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1321215000 USD
CY2013Q1 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1239354000 USD
CY2013Q1 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1239147000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1321019000 USD
CY2013Q1 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
247000 USD
CY2013Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
9822000 USD
CY2012Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
75393000 USD
CY2013Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
85615000 USD
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215421000 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219264000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215421000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
208018000 shares
CY2013Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, noncontrolling interest (Alios) and the income tax provision. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's significant accounting policies are described in Note&#160;A, "Nature of Business and Accounting Policies," in the 2012 Annual Report on Form&#160;10-K.</font></div></div>
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
217000 USD
CY2013Q1 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
40000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
21000 USD
CY2012Q1 vrtx Collaborative Revenues
CollaborativeRevenues
24381000 USD
CY2013Q1 vrtx Collaborative Revenues
CollaborativeRevenues
17414000 USD
CY2012Q4 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
268031000 USD
CY2013Q1 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
316821000 USD
CY2013Q1 vrtx Deferred Revenue Royalty Purchase Agreement
DeferredRevenueRoyaltyPurchaseAgreement
77800000 USD
CY2012Q1 vrtx Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
2289000 shares
CY2013Q1 vrtx Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
0 shares
CY2013Q1 vrtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndEmployeeStockPurchasePlan
0 shares
CY2012Q1 vrtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndEmployeeStockPurchasePlan
66000 shares
CY2011Q2 vrtx Initial Term Of Lease Agreement
InitialTermOfLeaseAgreement
P15Y
CY2012Q1 vrtx Interest Expense And Amortization Of Debt Issuance Costs
InterestExpenseAndAmortizationOfDebtIssuanceCosts
-3749000 USD
CY2013Q1 vrtx Interest Expense And Amortization Of Debt Issuance Costs
InterestExpenseAndAmortizationOfDebtIssuanceCosts
0 USD
CY2011Q2 vrtx Lease Agreement Number Of Leases
LeaseAgreementNumberOfLeases
2 leases
CY2011Q2 vrtx Lease Agreements Number Of Buildings
LeaseAgreementsNumberOfBuildings
2 building
CY2010Q1 vrtx Lease Term
LeaseTerm
P15Y
CY2011Q2 vrtx Optional Term Of Lease Agreement
OptionalTermOfLeaseAgreement
P10Y
CY2008 vrtx Proceeds From Sale Of Royalty Rights
ProceedsFromSaleOfRoyaltyRights
160000000 USD
CY2012Q1 vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
2486000 USD
CY2013Q1 vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
2665000 USD
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA
CY2011Q2 vrtx Square Footage Of Leased Property
SquareFootageOfLeasedProperty
1100000 squarefeet
CY2013Q1 vrtx Valuation Allowances And Reserves Provision
ValuationAllowancesAndReservesProvision
-68152000 USD
CY2013Q1 vrtx Valuation Allowances And Reserves Sales Credits Or Payments Current
ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent
-67752000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000875320
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
221400864 shares

Files In Submission

Name View Source Status
0000875320-13-000024-index-headers.html Edgar Link pending
0000875320-13-000024-index.html Edgar Link pending
0000875320-13-000024.txt Edgar Link pending
0000875320-13-000024-xbrl.zip Edgar Link pending
a2013q110-q.htm Edgar Link pending
a2013q110-q_exhibit3111.htm Edgar Link pending
a2013q110-q_exhibit3121.htm Edgar Link pending
a2013q110-q_exhibit3211.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20130331.xml Edgar Link completed
vrtx-20130331.xsd Edgar Link pending
vrtx-20130331_cal.xml Edgar Link unprocessable
vrtx-20130331_def.xml Edgar Link unprocessable
vrtx-20130331_lab.xml Edgar Link unprocessable
vrtx-20130331_pre.xml Edgar Link unprocessable